SCHEMBL270833

SCHEMBL270833

C[C]1OCCNC1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL467116 1.00
SCHEMBL8018826 0.73
SCHEMBL15415496 0.67 SLC6A2 (0.31)
SCHEMBL13091452 0.65 ITGB2 (0.41)
SCHEMBL29990871 0.65 ITGB2 (0.41)
SCHEMBL659729 0.60
SCHEMBL15015718 0.58
SCHEMBL18278887 0.56
SCHEMBL2045430 0.56
SCHEMBL10747631 0.56

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 398 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114302884-B Substituted pyridopyrimidinone compounds useful as T cell activators 百时美施贵宝公司 2024-06-04 CN claimed
EP-3766882-B1 PHTHALAZINE ISOXAZOLE ALKOXY DERIVATIVES, PREPARATION METHOD THEREOF, PHARMACEUTICAL COMPOSITION AND USE THEREOF SHANGHAI SIMR BIOTECHNOLOGY CO LTD (CN) 2023-08-23 EP claimed
CN-116547282-A Heterocyclic compounds and their use for the treatment of helminth infections and diseases 新基公司 2023-08-04 CN claimed
CN-110256440-B Phthalazine isoxazole alkoxy derivative, preparation method, pharmaceutical composition and application thereof 上海赛默罗生物科技有限公司 2023-05-23 CN claimed
CN-115243721-A Combination of DGK inhibitors and checkpoint antagonists 百时美施贵宝公司 2022-10-25 CN claimed
CN-108884029-B LSD1 inhibitors 米拉蒂医疗股份有限公司 2021-10-26 CN claimed
CN-109311880-B Novel tetrahydropyridopyrimidines for the treatment and prophylaxis of hepatitis B virus infections 豪夫迈·罗氏有限公司 2021-09-03 CN claimed
EP-3766882-A1 PHTHALAZINE ISOXAZOLE ALKOXY DERIVATIVES, PREPARATION METHOD THEREOF, PHARMACEUTICAL COMPOSITION AND USE THEREOF Shanghai Simr Biotechnology Co., Ltd. (CN) 2021-01-20 EP claimed
US-20210009598-A1 PHTHALAZINE ISOXAZOLE ALKOXY DERIVATIVES, PREPARATION METHOD THEREOF, PHARMACEUTICAL COMPOSITION AND USE THEREOF Shanghai SIMRD Biotechnology Co., Ltd (CN) 2021-01-14 US claimed
CN-111989321-A KRAS G12C inhibitors 米拉蒂治疗股份有限公司 2020-11-24 CN claimed
EP-1945219-A2 COMPOUND Cyclacel Limited (GB) 2008-07-23 EP claimed
WO-2007042786-A2 4 -HETEROARYL PYRIMIDINE DERIVATIVES AND USE THEREOF AS PROTEIN KINASE INHIBITORS CYCLACEL LIMITED (GB) 2007-04-19 WO claimed
US-20070010511-A1 Organic compounds NOVARTIS PHARMA AG (CH) 2007-01-11 US claimed
EP-0805152-B1 Cyclic amine substituted phenyl-alkyl-ketone and process for its preparation CIBA SC HOLDING AG (CH) 2005-06-08 EP claimed
EP-0866785-A1 DIARYL ACETYLENE KETONES BAYER AG (DE) 1998-09-30 EP claimed
US-5814629-A FUNGICIDES, BACTERICIDES AND VIRICIDES OF PLANTS NOVARTIS FINANCE CORPORATION (US) 1998-09-29 US claimed
US-5674864-A ANALGESICS; ENDOPEPTIDASE AND ENKEPHALINASE INHIBITORS; CARDIOTONIC, PSYCHOTROPIC AND HYPERTENSIVE AGENTS ROUSSEL UCLAF (FR) 1997-10-07 US claimed
WO-1997021658-A1 DIARYL ACETYLENE KETONES BAYER AKTIENGESELLSCHAFT (DE) 1997-06-19 WO claimed
EP-0465369-B1 N-substituted derivatives of alpha-mercapto alkylamines, process for their preparation and intermediates obtained, their use as medicaments and compositions containing them ROUSSEL UCLAF (FR) 1994-04-13 EP claimed
EP-0465369-A1 N-substituted derivatives of alpha-mercapto alkylamines, process for their preparation and intermediates obtained, their use as medicaments and compositions containing them ROUSSEL-UCLAF (FR) 1992-01-08 EP claimed